LifeSciVC

JULY 17, 2024

By Mike Cloonan, Chief Executive Officer of Sionna Therapeutics, as part of the From The Trenches feature of LifeSciVC The drug development process in rare diseases is rife with challenges especially when companies target significant differentiation or first-in-class targets.

Clinical Research 69

Clinical Research Disease Research Clinical Trials 69

Alta Sciences

JULY 28, 2023

Listen to the audiobook >>> ​​​ Issue 33 — CNS Drug Development: Integrated Solutions Lessen Complexity Hear about the complexities of CNS drug development programs and how an integrated CRO/CDMO can help move your molecule seamlessly from one phase to the next. Listen to the audiobook >>> Image Social Media Promo-01.jpg

Science 52

Science Clinical Research Clinical Trials Drug Development 52

LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 64

Drug Development Disease Drugs Treatment 64

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. Kristina is a pharmacist and holds a PhD in Medical Science from Linköping University.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

Drug Target Review

MARCH 4, 2025

Phenomix Sciences , led by CEO Mark Bagnall, is using precision medicine to make treatments more targeted and effective. In this interview, Bagnall explains how this approach is improving patient outcomes and driving the development of better obesity drugs. Mark is an entrepreneur and business manager in the healthcare industry.

Therapies 52

Therapies Treatment Clinical Trials Science 52

Drug Target Review

JULY 6, 2023

Animal testing plays a significant role in pre-clinical research and therefore requires the use of millions of animals. 1 Over a quarter of those were for basic research purposes, with most common areas focused on the immune system, the nervous system and oncology. In Britain, 2.88

Animal Testing 105

Animal Testing Drugs Clinical Trials Clinical Research 105

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Five Predictions for the Drug Development Industry in 2024 1.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Conversations in Drug Development Trends

DECEMBER 7, 2023

Despite a rapidly evolving clinical development landscape, we’ve remained grounded in medicine and science, helping sponsors achieve their clinical development goals across a range of therapeutic areas through our ability to adapt to changing client needs, deliver customized study teams, and dedicated scientific expertise.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

Advarra

AUGUST 10, 2023

Given the relatively small populations affected by any one rare disease or condition, a pharmaceutical company developing an orphan drug may reasonably expect the final approved drug to generate relatively small sales (when compared with the drug development costs) and consequently incur a financial loss.

Drug Development 52

Drug Development Disease Therapies Engineering 52

PPD

MAY 18, 2023

Yet, four out of five care partners of people with neurodegenerative disorders have never been informed of clinical trial opportunities , according to a survey of more than 250 caregivers conducted by PPD, the clinical research business of Thermo Fisher Scientific. There’s little time to lose.

Clinical Trials 86

Clinical Trials Trials Clinical Research Doctors 86

Precision for Medicine

JANUARY 23, 2023

QuartzBio’s suite of end-to-end SaaS solutions provides pharmaceutical and biotech clients with a fully connected data ecosystem linking sample, biomarker, and clinical data to improve collaboration, planning and R&D productivity. This convergence of trials, labs and data sciences is driving faster clinical development and approval.

Clinical Research 40

Clinical Research Research Engineering Clinical Development 40

Alta Sciences

JULY 18, 2023

Top 10 Life Science Resources pmjackson Tue, 07/18/2023 - 19:01 There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for you. There are several reasons why choosing Canada for your clinical trials can be beneficial.

Science 40

Science Clinical Trials FDA Trials 40

Alta Sciences

OCTOBER 15, 2024

As my experience in preclinical research grew, so did my curiosity in the overall drug development process; I wanted to expand into clinical research. Following that realization, I switched my goals to science, biology, and health, and started down my current career path. What Was your dream job as a child?

Pharmacokinetics 52

Pharmacokinetics Clinical Trials Drug Development Science 52

Perficient: Drug Development

FEBRUARY 1, 2024

The SCOPE (Summit for Clinical Ops Executives) conference is a premier event in the field of clinical operations, providing a comprehensive platform for professionals to explore the latest trends and innovations in clinical research. Are you attending SCOPE? Reach out to connect with us.

Science 59

Science Clinical Research Clinical Trials Trials 59

PPD

DECEMBER 7, 2023

The Sustainable Healthcare Coalition , a not-for-profit, health care sector-led group based in the United Kingdom, concluded that globally, clinical research could generate the equivalent of 100 million tons of carbon dioxide (CO2) emissions each year.

Clinical Trials 52

Clinical Trials Trials Clinical Research Science 52

The Pharma Data

OCTOBER 22, 2020

Supporting this atypical development pathway was the commitment of clinical trial investigators, patients and their families, and regulatory authorities – all working with the shared goal of rapidly advancing the science to help patients in need. Source: Gilead Sciences, Inc. . N Engl J Med. doi: 10.1056/NEJMoa2007764.

Science 52

Science Clinical Trials Hospitals Trials 52

Drug Target Review

FEBRUARY 29, 2024

From a very young age, I was drawn to science and medicine. This early exposure to bench science had a long-lasting impact. Through further research and work as a principal investigator on clinical studies for several central nervous system indications, I laid the groundwork for a career in gene therapy drug development.

Therapies 111

Therapies Disease Clinical Trials Science 111

PPD

DECEMBER 7, 2023

The Sustainable Healthcare Coalition , a not-for-profit, health care sector-led group based in the United Kingdom, concluded that globally, clinical research could generate the equivalent of 100 million tons of carbon dioxide (CO2) emissions each year.

Clinical Trials 52

Clinical Trials Trials Clinical Research Science 52

Conversations in Drug Development Trends

MARCH 1, 2023

The advent of outsourcing in clinical research came about in the 1980s based on transactional business-to-business interactions, which focused on the completion of specific development tasks. Instead, a CRO offering consultative services and strategic development elevates the full development program.

Clinical Research 52

Clinical Research Clinical Trials Science Trials 52

H1 Blog

JULY 30, 2024

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. The Impact of Draft Guidance on Drug Development As it stands, drug development is an expensive endeavor, costing approximately $2.3

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. billion by 2029.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Alta Sciences

MAY 28, 2024

Altasciences Receives 2024 CRO Leadership Award for Capabilities aasimakopoulos Wed, 05/29/2024 - 17:54 Laval, Québec, May 29, 2024 – Altasciences announced today that it has been recognized for excellence in contract research with a 2024 CRO Leadership Award for Capabilities.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Research 40

Conversations in Drug Development Trends

FEBRUARY 26, 2024

With the necessary prioritization of various factors when designing your clinical trial, the patient experience can be overlooked or improperly addressed in study design. However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success.

Clinical Trials 59

Clinical Trials Trials Disease Clinical Research 59

Drug Target Review

OCTOBER 16, 2024

I’ve always been drawn to the early stages of scientific discovery, where hypotheses are formed and developed into something tangible that can benefit patients. Being involved in these formative stages allows you to not only understand the challenges ahead but also shape the science to ensure it addresses patient needs.

Clinical Development 52

Clinical Development Drug Development Therapies Disease 52

The Pharma Data

NOVEMBER 1, 2020

Dr Nurbhai has more than 25 years of experience and a strong track record in the strategic and operational leadership of all phases of clinical research and development at companies across Europe and the US. Prior to VHsquared, Suhail was Senior Vice President and Head of Development and Medical Affairs for Shionogi in Europe.

Clinical Pharmacology 52

Clinical Pharmacology Small Molecule Clinical Research Science 52

LifeSciVC

JULY 11, 2023

The meeting brings together tens of thousands of physicians, scientists, patients, advocates, innovators, and those involved in oncology drug development from around the world in order to explore the latest advances in cancer treatment, clinical trials, and translational and clinical research.

Therapies 66

Therapies Trials Clinical Development Science 66

NIH Director's Blog: Drug Development

OCTOBER 11, 2022

Through the years, NIH has supported a total of 169 researchers who have received or shared 101 Nobel Prizes. That’s quite a testament to the world-leading science that NIH pursues and its continued impact on improving human health and well-being. Science 2008, 320 (5876), 664–667. [6] For Carolyn R. 2004 Jul;11(7):1009-1016.

Research 52

Research Small Molecule Science Clinical Research 52

Vial

FEBRUARY 8, 2024

To advance new therapies, pharmaceutical, biotech, and medical device companies engage contract research organizations (CROs) for their know-how in navigating the complex landscape of drug development and regulatory pathways and to run clinical trials. As von Itzstein et al.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. That is, how many clinical trials are actually managed by these organizations?

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

PPD

MAY 11, 2023

The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.

Vaccine 52

Vaccine Clinical Trials Long-Term Care Facilities Trials 52

The Pharma Data

DECEMBER 15, 2020

It is funded by the world’s leading charities dedicated to diabetes research, JDRF, and Diabetes UK, guided by both organizations’ strong commitment to facilitate deep interrogation of consolidated community-wide trial data as a means to accelerate clinical research and therapeutic development for T1D.

Drug Development 40

Drug Development Clinical Trials Trials Vaccine 40

Perficient: Drug Development

SEPTEMBER 25, 2024

As clinical trials grow more complex and data-intensive, addressing these pain points in data management becomes increasingly crucial for researchers and product teams. A Unified Clinical Trial Data Management Platform Life sciences leaders are engaging our industry experts to reimagine the clinical data review process.

Clinical Trials 52

Clinical Trials Trials Science Production 52

PPD

NOVEMBER 9, 2023

However, over the past decade, a trend toward incorporating multiple study populations into one protocol has slowly gathered momentum among drug developers. Improved prioritization Promising pipeline candidates with a strong early development protocol may see a positive impact to the net present value of an early-stage asset.

Clinical Development 52

Clinical Development Drug Development Clinical Research Treatment 52

The Pharma Data

SEPTEMBER 15, 2020

Irena Seredina holds a Medical Doctor, honors diploma and a Master of Science degree in Health Economics. During her medical practice, Seredina worked in clinical research as an investigator. He has worked for a number of partner research organizations in clinical development, including Biotrial, Celerion and Parexel.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Alta Sciences

JANUARY 31, 2025

Their passion and curiosity to expand the boundaries of toxicology research illuminated the room. As experts in early-phase drug development , from discovery through Phase II clinical research , we at Altasciences can share with STC members our accumulated knowledge and experience, and provide mentorship for future toxicologists.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

The Pharma Data

APRIL 17, 2021

The collaboration, launched in 2019, has successfully combined MD Anderson’s innovative clinical research infrastructure and the patient-driven drug development capabilities of the Therapeutics Discovery division with Boehringer Ingelheim’s pipeline of innovative cancer medicines and expertise in advancing breakthrough therapies.

Therapies 52

Therapies Drug Development Treatment Clinical Trials 52

Drug Target Review

DECEMBER 13, 2024

Antibody-drug conjugates treatment of small cell lung cancer: advances in clinical research. Fcgamma Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates. Antibody-drug conjugates: Principles and opportunities. MET alterations in advanced non-small cell lung cancer.

Therapies 98

Therapies Treatment Clinical Trials Drugs 98